Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. Rusterholz
126TiP SAKK 16/14: Anti-Pd-L1 Antibody Durvalumab (MEDI4736) in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small Cell Lung Cancer (NSCLC): A Multicenter Single-Arm Phase II Trial
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
Combining Antiangiogenic Therapy With Neoadjuvant Chemotherapy Increases Treatment Efficacy in Stage IIIA (N2) Non-Small Cell Lung Cancer Without Increasing Adverse Effects
Oncotarget
Oncology
P2.01-113 Prognostic Roles of Neoadjuvant and Adjuvant Chemotherapy for Treating Patients With Operable Stage III-N2 Non-Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Durvalumab in Frail and Elderly Patients With Stage Four Non-Small Cell Lung Cancer: Study Protocol of the Randomized Phase II DURATION Trial
Trials
Medicine
Pharmacology
Optimal Managements of Stage IIIA (N2) Non-Small Cell Lung Cancer Patients: A Population-Based Survival Analysis
Journal of Thoracic Disease
Pulmonary
Respiratory Medicine
P1.16-03 Prognostic Significance of PD-L1 in Stage II/III Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.17-14 Outcomes of Hypofractionated Radiation Therapy (HFRT) With Concurrent Chemotherapy in Patients With Stage III Non Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
A Phase II Trial of Midtreatment PET-CT Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Inoperable/Unresectable Non-Small Cell Lung Cancer (NSCLC)
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Preoperative Chemotherapy and Radiotherapy Concomitant to Cetuximab in Resectable Stage IIIB NSCLC: A Multicentre Phase 2 Trial (SAKK 16/08)
British Journal of Cancer
Cancer Research
Oncology
A Nomogram to Predict the Survival of Stage IIIA-N2 Non-Small Cell Lung Cancer After Surgery
Journal of Thoracic and Cardiovascular Surgery
Respiratory Medicine
Pulmonary
Cardiovascular Medicine
Surgery
Cardiology
